Top Markets
#1 Black Phoenix Black Phoenix +354.53%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.15%
#4 Akedo Akedo +52.53%
#5 Acurast Acurast +33.26%
#6 BasedHype BasedHype +27.64%
#7 Cryptopia Cryptopia +21.54%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.45%
#9 Avantis Avantis +18.91%
#10 HOME HOME +14.74%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Kedudukan dalam Saham #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Harga Saham
$0.0202
Disegerakkan terakhir: 2024-11-19
Modal Pasaran
$44.67K
Perubahan (1 hari)
-0.49%
Perubahan (1 tahun)
0.00%
Negara
IL
Perdagangan Notable Labs, Ltd. (NTBL)

Kategori

Healthcare
Pendapatan untuk Notable Labs, Ltd. (NTBL)
Pendapatan pada Jun 2024 TTM: $-8.99M
Menurut laporan kewangan terkini Notable Labs, Ltd., pendapatan semasa syarikat ialah $-8.99M. Pada tahun 2022, syarikat memperoleh pendapatan sebanyak $-14.41M, peningkatan berbanding pendapatan pada tahun 2021 yang berjumlah $-16.05M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Notable Labs, Ltd. dari 2015 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $-8.99M -20.23%
2023 $-11.26M -21.82%
2022 $-14.41M -10.25%
2021 $-16.05M -33.74%
2020 $-24.23M 24.90%
2019 $-19.40M -5.19%
2018 $-20.46M 101.80%
2017 $-10.14M -36.65%
2016 $-16.00M 7.48%
2015 $-14.89M 0.00%
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -58,807.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -21,810.07%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -33,552.61%
BE